List of bibliographic references
Number of relevant bibliographic references: 16.
| Ident. | Authors (with country if any) | Title |
|---|
| 000072 (1999) |
C. Fillebeen [France] ; V. Mitchell ; D. Dexter ; M. Benaissa ; J. Beauvillain ; G. Spik ; A. Pierce | Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment. |
| 000088 (1999) |
V. Ben [France] ; O. Blin ; B. Bruguerolle | Time-dependent striatal dopamine depletion after injection of 6-hydroxydopamine in the rat. Comparison of single bilateral and double bilateral lesions. |
| 000094 (2000) |
A. Boireau [France] ; P. Dubedat ; F. Bordier ; A. Imperato ; S. Moussaoui | The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP(+) accumulation. |
| 000133 (2000) |
E. Bezard [France] ; M. Jaber ; F. Gonon ; A. Boireau ; B. Bloch ; C E Gross | Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse. |
| 000196 (2001) |
T. Poyot [France] ; F. Condé ; M C Grégoire ; V. Frouin ; C. Coulon ; C. Fuseau ; F. Hinnen ; F. Dollé ; P. Hantraye ; M. Bottlaender | Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa. |
| 000465 (1992) |
F. Lisovoski [France] ; C. Haby ; E. Borrelli ; C. Schleef ; M O Revel ; C. Hindelang ; J. Zwiller | Induction of D2 dopamine receptor mRNA synthesis in a 6-hydroxydopamine parkinsonian rat model. |
| 000A58 (1990) |
S. Malessa [France] ; E C Hirsch ; P. Cervera ; C. Duyckaerts ; Yves Agid [France] | Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes: a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration. |
| 000B19 (2010) |
Sylvia Navailles [France] ; Abdelhamid Benazzouz ; Bernard Bioulac ; Christian Gross ; Philippe De Deurwaerdère | High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease. |
| 000C44 (1990) |
R. Raisman-Vozari [France] ; J A Girault ; S. Moussaoui ; C. Feuerstein ; P. Jenner ; C D Marsden ; Yves Agid [France] | Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man. |
| 000C56 (2010) |
Pierre-Olivier Fernagut [France] ; Qin Li [Royaume-Uni, République populaire de Chine] ; Sandra Dovero [France] ; Piu Chan [République populaire de Chine] ; Tao Wu [République populaire de Chine] ; Paula Ravenscroft [Royaume-Uni] ; Michael Hill [Royaume-Uni] ; Zhenwen Chen [République populaire de Chine] ; Erwan Bezard [France, République populaire de Chine] | Dopamine Transporter Binding Is Unaffected by L-DOPA Administration in Normal and MPTP-Treated Monkeys |
| 001436 (2014) |
Wisam Dieb [France] ; Omar Ouachikh [France] ; Franck Durif [France] ; Aziz Hafidi [France] | Lesion of the dopaminergic nigrostriatal pathway induces trigeminal dynamic mechanical allodynia |
| 001670 (2015) |
Gaynor A. Smith [États-Unis] ; Emily M. Rocha [États-Unis] ; Thomas Rooney [France] ; Pascal Barneoud [France] ; Jesse R. Mclean [États-Unis] ; Jonathan Beagan [États-Unis] ; Teresia Osborn [États-Unis] ; Madeleine Coimbra [France] ; Yongyi Luo [États-Unis] ; Penelope J. Hallett [États-Unis] ; Ole Isacson [États-Unis] | A Nurr1 Agonist Causes Neuroprotection in a Parkinson’s Disease Lesion Model Primed with the Toll-Like Receptor 3 dsRNA Inflammatory Stimulant Poly(I:C) |
| 001C18 (1989) |
D. Scherman [France] ; C. Desnos ; F. Darchen ; P. Pollak ; F. Javoy-Agid ; Yves Agid [France] | Striatal dopamine deficiency in Parkinson's disease: role of aging. |
| 001C58 (1995) |
R. Levy [France] ; M T Herrero ; M. Ruberg ; J. Villares ; B. Faucheux ; J. Guridi ; J. Guillen ; M R Luquin ; F. Javoy-Agid ; J A Obeso | Effects of nigrostriatal denervation and L-dopa therapy on the GABAergic neurons in the striatum in MPTP-treated monkeys and Parkinson's disease: an in situ hybridization study of GAD67 mRNA. |
| 001E34 (1996) |
P. Barnéoud [France] ; M. Mazadier ; J M Miquet ; S. Parmentier ; P. Dubédat ; A. Doble ; A. Boireau | Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat. |
| 001F18 (1998) |
M G Murer [France] ; G. Dziewczapolski ; L B Menalled ; M C García ; Yves Agid [France] ; O. Gershanik ; R. Raisman-Vozari | Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Parkinson Disease, Secondary (metabolism)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i \
-Sk "Parkinson Disease, Secondary (metabolism)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Ncbi
|étape= Curation
|type= indexItem
|index= KwdEn.i
|clé= Parkinson Disease, Secondary (metabolism)
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024 |  |
